Study2018

Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome

Sullivan EM, Pennington ER, Sparagna GC, Torres MJ, Neufer PD, Harris M, Washington J, Anderson EJ, Zeczycki TN, Brown DA, Shaikh SR

The Journal of biological chemistry · 49 citations

Review labels

Mechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Animal study (classified by our AI screen)
Studied in
People, plus animal or lab work
Main outcome
Mechanisms only

Who paid for it

Funding
Independent funding
Government
National Institutes of Health
Government
National Heart, Lung, and Blood Institute
Government
National Institute of Diabetes and Digestive and Kidney Diseases
Government
National Center for Complementary and Integrative Health
Government
NHLBI NIH HHS
Government
NCCIH NIH HHS
Government
NIDDK NIH HHS
Grants
National Heart, Lung, and Blood Institute (R01 HL123647); National Heart, Lung, and Blood Institute (R01 HL122863); National Institute of Diabetes and Digestive and Kidney Diseases (P30DK-056350); National Center for Complementary and Integrative Health (R01 AT008375); National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK110656); National Institutes of Health (P30-DK056350); National Institutes of Health (R01DK110656); National Institutes of Health (R01HL123647); National Institutes of Health (R01AT008375); National Institutes of Health (R01HL122863)

Based on 7 listed funder(s).

Publication

Published
2017-11-21 · J Biol Chem · vol. 293 · issue 2 · pp. 466–483
Publisher
Elsevier BV
Cited
54 citations · more than 93% of similar papers · 3.4× the field average
Impact
Top 10% most cited in its field
References
89 works
Access
Open access (hybrid journal) · CC-BY
Research areas
Fatty Acid Research and Health · Lipid metabolism and biosynthesis · Metabolomics and Mass Spectrometry Studies
Keywords
Docosahexaenoic acid, Phospholipid, Biochemistry, Phosphatidylethanolamine, Enzyme, Linoleic acid, Cardiolipin, Biology, Mitochondrion, Phosphatidylcholine, Polyunsaturated fatty acid, Respiratory chain, Fatty acid, Chemistry, Membrane
MeSH
myocardium, heart, mitochondria, heart, humans, docosahexaenoic acids, eicosapentaenoic acid, fatty acids, unsaturated, linoleic acid, phospholipids, phosphatidylcholines, phosphatidylethanolamines, cardiolipins, mass spectrometry

11 authors

From US

  • E. Madison SullivanEast Carolina University
  • Edward Ross PenningtonUniversity of North Carolina at Chapel Hill; East Carolina University
  • Genevieve C. SparagnaUniversity of Colorado Anschutz; University of Colorado Denver
  • Maria J. TorresEast Carolina University
  • Peter Darrell NeuferEast Carolina University
  • Mitchel HarrisEast Carolina University

Abstract

Cardiac mitochondrial phospholipid acyl chains regulate respiratory enzymatic activity. In several diseases, the rodent cardiac phospholipidome is extensively rearranged; however, whether specific acyl chains impair respiratory enzyme function is unknown. One unique remodeling event in the myocardium of obese and diabetic rodents is an increase in docosahexaenoic acid (DHA) levels. Here, we first confirmed that cardiac DHA levels are elevated in diabetic humans relative to controls. We then used dietary supplementation of a Western diet with DHA as a tool to promote cardiac acyl chain remodeling and to study its influence on respiratory enzyme function. DHA extensively remodeled the acyl chains of cardiolipin (CL), mono-lyso CL, phosphatidylcholine, and phosphatidylethanolamine. Moreover, DHA lowered enzyme activities of respiratory complexes I, IV, V, and I+III. Mechanistically, the reduction in enzymatic activities were not driven by a dramatic reduction in the abundance of supercomplexes. Instead, replacement of tetralinoleoyl-CL with tetradocosahexaenoyl-CL in biomimetic membranes prevented formation of phospholipid domains that regulate enzyme activity. Tetradocosahexaenoyl-CL inhibited domain organization due to favorable Gibbs free energy of phospholipid mixing. Furthermore, in vitro substitution of tetralinoleoyl-CL with tetradocosahexaenoyl-CL blocked complex-IV binding. Finally, reintroduction of linoleic acid, via fusion of phospholipid vesicles to mitochondria isolated from DHA-fed mice, rescued the major losses in the mitochondrial phospholipidome and complexes I, IV, and V activities. Altogether, our results show that replacing linoleic acid with DHA lowers select cardiac enzyme activities by potentially targeting domain organization and phospholipid-protein binding, which has implications for the ongoing debate about polyunsaturated fatty acids and cardiac health.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.